SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX)
AFFX 14.010.0%Apr 1 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: lwd who wrote (588)12/29/1997 5:36:00 PM
From: Boyce Burge  Read Replies (1) of 1728
 
I think this buy out of Synteni shows how able INCY's management is in making sure they capture needed technology. 80 mil is cheap. A lot of people at Stanford are now a few million richer. Now INCY is a gene chip co too. This explains why INCY has come back to 40 in the last few days. And maybe why AFFX has swooned to 30.

INCY is a scraper. AFFX will have to struggle with INCY to keep the attention on its own arrays. But, both should do well in the long run... and buy some ABSC too. And also some GILD!!.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News